Edward P. Feener is CHIEF SCIENTIFIC OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 72,858 shares of KALV, which is worth approximately $652,807. The most recent transaction as insider was on Jun 01, 2021, when has been sold 25,800 shares (Common Stock) at a price of $27.01 per share, resulting in proceeds of $696,858. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.9K
0% 3M change
8.73% 12M change
Total Value Held $652,807

Edward P. Feener Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2021
SELL
Open market or private sale
$696,858 $27.01 p/Share
25,800 Reduced 53.49%
22,434 Common Stock
May 03 2021
SELL
Open market or private sale
$149,040 $24.84 p/Share
6,000 Reduced 9.96%
54,234 Common Stock
May 03 2021
BUY
Exercise of conversion of derivative security
$61,260 $10.21 p/Share
6,000 Added 9.06%
60,234 Common Stock
Feb 23 2021
SELL
Open market or private sale
$1,035,400 $33.4 p/Share
31,000 Reduced 36.37%
54,234 Common Stock
Feb 07 2021
BUY
Grant, award, or other acquisition
-
12,500 Added 12.79%
85,234 Common Stock
Nov 02 2020
SELL
Open market or private sale
$102,840 $17.14 p/Share
6,000 Reduced 7.62%
72,734 Common Stock
Oct 21 2020
SELL
Open market or private sale
$163,927 $18.2 p/Share
9,007 Reduced 10.27%
78,734 Common Stock
Oct 20 2020
SELL
Open market or private sale
$139,277 $17.63 p/Share
7,900 Reduced 8.26%
87,741 Common Stock
Oct 16 2020
SELL
Open market or private sale
$16,881 $17.0 p/Share
993 Reduced 1.03%
95,641 Common Stock
EPF

Edward P. Feener

CHIEF SCIENTIFIC OFFICER
Cambridge, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV